Advertisement

Th1/Th2 Cytokine Network

  • M. M. D’Elios
  • G. Del Prete
Part of the Topics in Neuroscience book series (TOPNEURO)

Abstract

The immune system has evolved different defensive mechanisms against pathogens. The first defensive line is provided by “natural” immunity, including phagocytes, T cell receptor (TCR) γδ+ T cells, natural killer (NK) cells, mast cells, neutrophils and eosinophils, as well as complement components and proinflammatory cytokines, such as interferons (IFNs), interleukin (IL)-1, IL-6, IL-12, IL-18 and tumor necrosis factor (TNF)-α. The more specialized TCR αβ+ T lymphocytes provide the second defense wall. These cells account for the “specific immunity”, which results in specialized types of immune responses which allow vertebrates to recognize and eliminate, or at least control, infectious agents in different body compartments. Viruses growing within infected cells are faced through the killing of their host cells by CD8+ class I MHC-restricted cytotoxic T lymphocytes. Most microbial components are endocytosed by antigen-presenting cells (APC), processed and presented preferentially to CD4+ class II MHC-restricted T helper (Th) cells. CD4+ T cells co-operate with B cells for the production of antibodies which opsonize extracellular microbes and neutralize their exotoxins. This branch of the specific Th cell-mediated immune response is known as “humoral immunity”. Other microbes, however, survive within macrophages despite the unfavorable microenvironment. Antigen-activated CD4+ Th cells are required to activate macrophages, whose reactive metabolites and TNF-α finally lead to the destruction of pathogens.

Keywords

Systemic Lupus Erythematosus Experimental Autoimmune Encephalomyelitis Visceral Leishmaniasis Leukemia Inhibitory Factor Cutaneous Leishmaniasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mosmann TR, Cherwinski H, Bond MW et al. (1986) Two types of murine T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136: 2348–2357PubMedGoogle Scholar
  2. 2.
    Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 7:145–173CrossRefGoogle Scholar
  3. 3.
    Del Prete G, De Carli M, Mastromauro C et al. (1991) Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest 88: 346–351PubMedCrossRefGoogle Scholar
  4. 4.
    Mosmann TR, Sad S (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17: 138–146PubMedCrossRefGoogle Scholar
  5. 5.
    Ferrick DA, Schrenzel MD, Mulvania T (1995) Differential production of IFN-γ and IL-4 in response to Th1- and Th2-stimulating pathogens by gamma delta T cells in vivo. Nature 373: 255–258PubMedCrossRefGoogle Scholar
  6. 6.
    Paliard X, de Waal Malefijt R, Yssel H, et al. (1988) Simultaneous production of IL-2, IL-4, and IFN-γ by activated human CD4+ and CD8+ T cell clones. J Immunol 141:849–858PubMedGoogle Scholar
  7. 7.
    Openshaw P, Murphy EE, Hosken NA et al. (1995) Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J Exp Med 182: 1357–1367PubMedCrossRefGoogle Scholar
  8. 8.
    Salgame P, Abrams JS, Clayberger C et al. (1995) Differing lymphokine profiles and functional subsets of human CD4+ and CD8+ T cell clones. Science 254: 279–281CrossRefGoogle Scholar
  9. 9.
    Romagnani S (1995) Biology of human Th1 and Th2 cells. J Clin Immunol 15: 121–129PubMedCrossRefGoogle Scholar
  10. 10.
    Del Prete G, De Carli M, Almerigogna F et al. (1993) Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 150: 353–360PubMedGoogle Scholar
  11. 11.
    Del Prete G, De Carli M, Ricci M, Romagnani S (1991) Helper activity for immunoglobulin synthesis by Th1 and Th2 human T-cell clones: The help of Th1 clones is limited by their cytolytic capacity. J Exp Med 174: 809–813PubMedCrossRefGoogle Scholar
  12. 12.
    Del Prete G, De Carli M, Lammel RM et al. (1995) Th1 and Th2 T-helper cells exert opposite regulatory effects on procoagulant activity and tissue factor production by human monocytes. Blood 86: 250–257PubMedGoogle Scholar
  13. 13.
    Del Prete G, De Carli M, Almerigogna F et al. (1995) Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. FASEB J 9: 81–86PubMedGoogle Scholar
  14. 14.
    Del Prete G, De Carli M, D’Elios MM et al. (1995) CD30-mediated signalling promotes the development of human Th2-like T cells. J Exp Med 182:1655–1661PubMedCrossRefGoogle Scholar
  15. 15.
    D’Elios MM, Romagnani P, Scaletti C et al. (1997) In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells. J Leukoc Biol 61: 539–544PubMedGoogle Scholar
  16. 16.
    Annunziato F.Manetti R,Tomasevic L et al. (1996) Expression and release of LAG-3-associated protein by human CD4+ T cells are associated with IFN-γ. FASEB J 10:767–776Google Scholar
  17. 17.
    Nakamura T, Lee RK, Nam SY et al. (1997) Reciprocal regulation of CD30 expression on CD4+ T cells by IL-4 and IFN-γ. J Immunol 158: 2090–2098PubMedGoogle Scholar
  18. 18.
    Scheel D, Richter E, Toellner K-M et al. (1995) Correlation of CD26 expression with Th1-like reactions in granulomatous diseases. In: Schlossmann SF (ed) Leukocyte typing V. White cell differentiation antigens. Oxford University, Oxford, pp 1101–1111Google Scholar
  19. 19.
    Kanegane H, Kasahara Y, Niida Y et al. (1996) Expression of L-selectin (CD62L) discriminates Th1- and Th2-like cytokine-producing memory CD4+ T cells. Immunology 87:186–190PubMedCrossRefGoogle Scholar
  20. 20.
    Assenmacher M, Scheffold A, Schmitz J et al. (1996) Specific expression of surface interferon-γ on interferon-γ-producing T cells from mouse and man. Eur J Immunol 26: 263–267PubMedCrossRefGoogle Scholar
  21. 21.
    Sallusto F, Mackay CR, Lanzavecchia A (1997) Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277: 2005–2007PubMedCrossRefGoogle Scholar
  22. 22.
    Bonecchi R, Bianchi R, Panina-Bordignon P et al. (1998) Differential expression of chemokine receptors and chemotactic responsiveness of Th1 and Th2 cells. J Exp Med 187: 129–134PubMedCrossRefGoogle Scholar
  23. 23.
    Loetscher P, Uguccioni MG, Bordoli L et al. (1998) CCR5 is characteristic of Th1 lymphocytes. Nature 391: 344–345PubMedCrossRefGoogle Scholar
  24. 24.
    Rogge L, Barberis-Maino L, Biffi M et al. (1997) Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 185: 825–831PubMedCrossRefGoogle Scholar
  25. 25.
    Kamogawa Y, Minasi LE, Carding SR et al. (1993) The relationship of IL-4- and IFN-γ-producing T cells studied by lineage ablation of IL-4-producing cells. Cell 75: 985–995PubMedCrossRefGoogle Scholar
  26. 26.
    Swain SL, Weinberg AD, English M (1990) CD4+ T cell subsets. Lymphokine secretion of memory cells and of effector cells that develop from precursors in vitro. J Immunol 144: 1788–1799PubMedGoogle Scholar
  27. 27.
    Parronchi P, De Carli M, Manetti R et al. (1992) IL-4 and IFNs (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 and Th2 human T cell clones. J Immunol 149: 2977–2982PubMedGoogle Scholar
  28. 28.
    Hsieh CS, Macatonia SE, Tripp CS et al. (1993) Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260: 547–549PubMedCrossRefGoogle Scholar
  29. 29.
    Manetti R, Parronchi P, Giudizi MG et al. (1993) Natural killer cell stimulatory factor (IL-12) induces T helper type 1 (Thl)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 177:1199–1204PubMedCrossRefGoogle Scholar
  30. 31.
    Okamura H, Kashiwamura S, Tsutsui H (1998) Regulation of IFN-γ production by IL-12 and IL-18. Curr Opin Immunol 10: 259–264PubMedCrossRefGoogle Scholar
  31. 31.
    Constant SL, Bottomly K (1997) Induction of Thl and Th2 CD4+ T cell responses: The alternative approaches. Annu Rev Immunol 15: 297–322PubMedCrossRefGoogle Scholar
  32. 32.
    Szabo S, Jacobson NG, Dighe AS et al. (1995) Developmental committment to the Th2 lineage by extinction of IL-12 signaling. Immunity 2: 665–675PubMedCrossRefGoogle Scholar
  33. 33.
    Hill GR, Cooke KR, Teshima T, Ferrara JL (1998) IL-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation. J Clin Invest 102:115–123PubMedCrossRefGoogle Scholar
  34. 34.
    Hilkens CM, Snijders A, Kapsenberg M (1996) Accessory cell-derived IL-12 and PGE2 determine the IFN-γ level of activated human CD4+ T cells. J Immunol 156:1722–1727PubMedGoogle Scholar
  35. 35.
    Gorham JD, Guler ML, Steen RG et al. (1996) Genetic mapping of a locus controlling development of Thl/Th2 type responses. Proc Natl Acad Sci USA 93:12467–12472PubMedCrossRefGoogle Scholar
  36. 36.
    Bacon CM, Petricoin EF, Ortaldo JE et al. (1995) Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc Natl Acad Sci USA 92:7307–7311PubMedCrossRefGoogle Scholar
  37. 37.
    Rincon M, Flavell RA (1997) T cell subsets: Transcriptional control in the Thl/Th2 decision. Curr Biol 7: 729–732CrossRefGoogle Scholar
  38. 38.
    Murphy KM (1998) T lymhpocyte differentiation in the periphery. Curr Opin Immunol 10: 226–232PubMedCrossRefGoogle Scholar
  39. 39.
    Takeda K, Tanaka T, Shi W et al. (1996) Essential role of STAT6 in IL-4 signalling. Nature 380: 627–633PubMedCrossRefGoogle Scholar
  40. 40.
    Szabo SJ, Glimcher LH, Ho IC (1997) Genes that regulate interleukin-4 expression in T cells. Curr Opin Immunol 9: 775–781CrossRefGoogle Scholar
  41. 41.
    Zheng W, Flavell RA (1997) The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells Cell 89: 587–596Google Scholar
  42. 42.
    Romagnani S (1994) Lymphokine production by human T cells in disease states. Annu Rev Immunol 12:227–257PubMedCrossRefGoogle Scholar
  43. 43.
    Reiner SL, Locksley RM (1995) The regulation of immunity to Leishmania major. Annu Rev Immunol 13:151–177PubMedCrossRefGoogle Scholar
  44. 44.
    Carvalho EM, Bacellar O, Brownell C et al. (1994) Restoration of IFN-γ production and lymphocyte proliferation in visceral leishmaniasis. J Immunol 152: 5949–5956PubMedGoogle Scholar
  45. 45.
    Kemp M, Theander TG, Kharazmi A (1996) The contrasting roles of CD4+ T cells in intracellular infections in humans: Leishmaniasis as an example. Immunol Today 17: 13–16PubMedCrossRefGoogle Scholar
  46. 46.
    Pirmez S, Yamamura M, Uyemura K et al. (1993) Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest 91: 1390–1395PubMedCrossRefGoogle Scholar
  47. 47.
    Badarò R, Johnson WD (1993) The role of interferon-γ in the treatment of visceral and diffuse cutaneous leishmaniasis. J Infect Dis 167(S1): S13–17PubMedCrossRefGoogle Scholar
  48. 48.
    Finkelman FD, Pearce EJ, Urban JF Jr, Sher A (1991) Regulation and biological function of helminth-induced cytokine responses. Immunoparasitol Today 12: A62–66CrossRefGoogle Scholar
  49. 49.
    Sher A, Gazzinelli RT, Oswald IP et al. (1992) Role of T cell derived cytokines in the down regulation of immune responses in parasitic and retroviral infection. Immunol Rev 127:183–204PubMedCrossRefGoogle Scholar
  50. 50.
    Cooper MA, Dalton DK, Stewart TA, Orme JM (1993) Disseminated tuberculosis in IFN-γ gene-disrupted mice. J Exp Med 178: 2249–2254CrossRefGoogle Scholar
  51. 51.
    Flynn JL, Chan J, Trieblod KJ et al. (1993) An essential role for IFN-γ in resistance to Mycobacterium tuberculosis. J Exp Med 178:2249–2254PubMedCrossRefGoogle Scholar
  52. 52.
    Newport MJ, Huxley CM, Huston S, Levin M (1996) A mutation in IFN-γ receptor gene and sensitivity to mycobacterial infection. N Engl J Med 335:1941–1949PubMedCrossRefGoogle Scholar
  53. 53.
    de Jong R, Altare F, Elferink DG, Ottenhoff TH (1998) Severe mycobacterial and salmonella infections in IL-12 receptor-deficient patients. Science 280:1435–1438PubMedCrossRefGoogle Scholar
  54. 54.
    Daugelat S, Kauffman SH (1995) Role of Thl and Th2 cells in bacterial infections. Chem Immunol 63: 66–97CrossRefGoogle Scholar
  55. 55.
    Yssel H, Shanafelt MC, Soderberg C et al. (1992) Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis. J Exp Med 174: 593–601CrossRefGoogle Scholar
  56. 56.
    Lahesmaa R, Yssel H, Batsford S et al. (1992) Yersinia enterocolitica activates a T helper type 1-like T cell subset in reactive arthritis. J Immunol 148: 3079–3085PubMedGoogle Scholar
  57. 57.
    Mohammadi M, Czinn S, Nedrud J (1996) Helicobacter-specific cell-mediated immune responses display a predominant Thl phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J Immunol 156: 4729–4736PubMedGoogle Scholar
  58. 58.
    D’EIios MM, Manghetti M, De Carli M et al. (1997) Thl effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol 158: 962–967Google Scholar
  59. 59.
    Wierenga EA, Snoek M, de Groot C et al. (1990) Evidence for compartmentalization of functional subsets of CD4+ T lymphocytes in atopic patients. J Immunol 144:4651–4656PubMedGoogle Scholar
  60. 60.
    Parronchi P, Macchia D, Piccinni M-P et al. (1991) Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci USA 88:4538–4542PubMedCrossRefGoogle Scholar
  61. 61.
    Kay AB, Ying S, Varney V et al. (1991) Messenger RNA expression of the cytokine gene cluster interleukin-3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase reactions in atopic subjects. J Exp Med 173:775–778PubMedCrossRefGoogle Scholar
  62. 62.
    Maggi E, Biswas P, Del Prete G et al. (1991) Accumulation of Th2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J Immunol 146: 1169–1174PubMedGoogle Scholar
  63. 63.
    van der Heijden FL, Wierenga EA, Bos JD, Kapsenberg ML (1991) High frequency of IL-4-producing CD4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 97: 389–394PubMedCrossRefGoogle Scholar
  64. 64.
    Robinson DS, Hamid Q, Ying S et al. (1992) Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 326: 295–304CrossRefGoogle Scholar
  65. 65.
    Del Prete G, De Carli M, D’EIios MM et al. (1993) Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur J Immunol 23: 1445–1449PubMedCrossRefGoogle Scholar
  66. 66.
    Robinson D, Hamid Q, Bentley A et al. (1993) Activation of CD4+ T cells, increased Th2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 92: 313–324PubMedCrossRefGoogle Scholar
  67. 67.
    Varney VA, Hamid Q, Gaga M et al. (1993) Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 92: 644–651PubMedCrossRefGoogle Scholar
  68. 68.
    Secrist H, Chelen CJ, Wen Y et al. (1993) Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 178: 2123–2130PubMedCrossRefGoogle Scholar
  69. 69.
    Jutel M, Pichler WJ, Skrbic D et al. (1995) Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures. J Immunol 154: 4187–4194PubMedGoogle Scholar
  70. 70.
    Romagnani S (1995) Atopic allergy and other hypersensitivities. Curr Opin Immunol 7:745–750PubMedCrossRefGoogle Scholar
  71. 71.
    Suthantiran M, Strom TB (1995) Immunobiology and immunopharmacology of organ allograft rejection. I Clin Immunol 15:161–171CrossRefGoogle Scholar
  72. 72.
    D’Elios MM, Josien R, Manghetti M et al. (1997) Predominant Thl infiltration in acute rejection episodes of human kidney grafts. Kidney Int 51:1876–1884PubMedCrossRefGoogle Scholar
  73. 73.
    Dallman MJ (1995) Cytokines and transplantation: Thl/Th2 regulation of the immune response to solid organ transplants in the adult. Curr Opin Immunol 7:632–638PubMedCrossRefGoogle Scholar
  74. 74.
    Wegmann TG, Lin H, Gulbert L, Mossman TR (1993) Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 14: 353–356PubMedCrossRefGoogle Scholar
  75. 75.
    Piccinni M-P, Beloni L, Giannarini L et al. (1995) Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Thl cell clones. J Immunol 155:128–133PubMedGoogle Scholar
  76. 76.
    Piccinni M-P, Beloni L, Livi C et al. (1998) Role of type 2 T helper (Th2) cytokines and leukemia inhibitory factor (LIF) produced by decidual T cells in unexplained recurrent abortions. Nat Med (in press)Google Scholar
  77. 77.
    Robb L, Li R, Hartely L, Begley (1998) Infertility in female mice lacking the receptor for IL-11 is due to a defective uterine response to implantation. Nat Med 4: 303–308PubMedCrossRefGoogle Scholar
  78. 78.
    Piccinni M–P, Romagnani S (1996) Regulation of fetal allograft survival by hormone-controlled Thl- and Th2-type cytokines. Immunol Res 15:141–150PubMedCrossRefGoogle Scholar
  79. 79.
    Romagnani S (1997) The Thl/Th2 paradigm in disease. Springer-Verlag, Berlin Heidelberg New YorkGoogle Scholar
  80. 80.
    Windhagen A, Nicholson LB, Weiner HL et al. (1996) Role of Thl and Th2 cells in neurologic disorders. Chem Immunol 63:171–186PubMedCrossRefGoogle Scholar
  81. 81.
    Khoury SJ, Hancock WW, Weiner HL (1992) Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with down regulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4 and prostaglandin E expression in the brain. J Exp Med 176: 1335–1364CrossRefGoogle Scholar
  82. 82.
    Cua DJ, Hinton DR, Stohlman SA (1995) Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. J Immunol 155: 4052–4059PubMedGoogle Scholar
  83. 83.
    Ferber IA, Brocke S, Taylor-Edwards C et al. (1996) Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 156: 5–7PubMedGoogle Scholar
  84. 84.
    Sharief MK, Hentges A (1991) Association between tumor necrosis factor alpha and disease progression in patients with multiple sclerosis. N Engl J Med 325: 467–472PubMedCrossRefGoogle Scholar
  85. 85.
    Brod SA, Benjamin D, Hafler DA (1991) Restricted T cell expression of IL2/IFN-γ mRNA in human inflammatory disease. J Immunol 147: 810–815PubMedGoogle Scholar
  86. 86.
    Olsson T (1993) Cytokines in neuroinflammatory disease: Role of myelin-autoreactive T cell production of interferon-gamma. J Neuroimmunol 40: 211–218CrossRefGoogle Scholar
  87. 87.
    Del Prete G, Tiri A, Mariotti S et al. (1987) Enhanced production of gamma-interferon by thyroid-derived T cell clones from patients with Hashimoto’s thyroiditis. Clin Exp Immunol 69: 323–331PubMedGoogle Scholar
  88. 88.
    Margolick JB, Weetman AP, Burman KD (1988) Immunohistochemical analysis of intrathyroidal lymphocytes in Graves’ disease: evidence of activated T cells and production of interferon-gamma. Clin Immunol Immunopathol 47: 208–218PubMedCrossRefGoogle Scholar
  89. 89.
    Zheng RQH, Abney ER, Chu CQ et al. (1992) Detection of in vivo production of tumor necrosis factor-alpha by human thyroid epithelial cells. Immunology 75: 456–462PubMedGoogle Scholar
  90. 90.
    De Carli M, D’Elios MM, Mariotti S et al. (1993) Cytolytic T cells with Thl-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves’ ophthalmopathy. J Clin Endocrinol Metab 77:1120–1124PubMedCrossRefGoogle Scholar
  91. 91.
    Mullins RJ, Cohen SBA, Webb LMC et al. (1995) Identification of thyroid stimulating hormone receptor-specific T cells in Graves’ disease thyroid using autoantigen-transfected Epstein Barr virus-transformed B cell lines. J Clin Invest 96: 30–37PubMedCrossRefGoogle Scholar
  92. 92.
    Kirsner JB, Shorter RG (1982) Recent developments in “nonspecific” inflammatory bowel disease. N Engl J Med 306: 775–837PubMedCrossRefGoogle Scholar
  93. 93.
    Niessner M, Volk BA (1995) Altered Thl/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 101: 428–435PubMedCrossRefGoogle Scholar
  94. 94.
    Parronchi P, Romagnani P, Annunziato F et al. (1997) Type 1 T-helper cells predominance and interleukin-12 expression in the gut of patients with Crohn’s disease. Am J Pathol 150: 823–831PubMedGoogle Scholar
  95. 95.
    Goldman M, Druet P, Gleichmann E (1991) Th2 cells in systemic autoimmunity: Insights from allogenic diseases and chemically-induced autoimmunity. Immunol Today 12:223–227PubMedCrossRefGoogle Scholar
  96. 96.
    Prigent P, Saoudi A, Pannetier C et al. (1995) Mercuric chloride, a chemical responsible for T helper cell (Th)2-mediated autoimmunity in Brown Norway rats, directly triggers T cells to produce interleukin-4. J Clin Invest 96:1484–1489PubMedCrossRefGoogle Scholar
  97. 97.
    Dueymes M, Barrier J, Bescancenot JF et al. (1993) Relationship of IL-4 to isotypic distribution of anti-DS DNA antibodies in SLE. Int Arch Allergy Appl Immunol 101: 408–415CrossRefGoogle Scholar
  98. 98.
    Hagiwara E, Gourley MF, Lee M, Klinman DM (1996) Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of IL-10/IFN-γ secreting cells in the peripheral blood. Arthritis Rheum 39: 379–385PubMedCrossRefGoogle Scholar
  99. 99.
    Caligaris-Cappio F, Bertero MT, Converso M et al. (1995) Circulating levels of soluble CD30, a marker of cells producing Th2-type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity. Clin Exp Rheum 13: 339–343Google Scholar
  100. 100.
    Kovacs EJ (1991) Fibrogenic cytokines: The role of immune mediators in the development of scar tissue. Immunol Today 12:17–23PubMedCrossRefGoogle Scholar
  101. 101.
    Postletwhite AE, Holness MA, Katai H, Raghow R (1992) Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest 90: 1479–1485CrossRefGoogle Scholar
  102. 102.
    Famularo G, Procopio A, Giacomelli R et al. (1990) Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis. Clin Exp Immunol 81: 368–372PubMedCrossRefGoogle Scholar
  103. 103.
    Mavilia C, Scaletti C, Romagnani P et al. (1997) Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis. Am J Pathol 151:1751–1758Google Scholar

Copyright information

© Springer-Verlag Italia 1999

Authors and Affiliations

  • M. M. D’Elios
    • 1
  • G. Del Prete
    • 1
  1. 1.Institute of Internal Medicine and ImmunoallergologyUniversity of FlorenceFlorenceItaly

Personalised recommendations